Scotia Capital’s Cellectar Biosciences CLRB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-38
Closed -$5K 789
2022
Q2
$5K Sell
38
-1
-3% -$132 ﹤0.01% 804
2022
Q1
$8K Buy
39
+1
+3% +$205 ﹤0.01% 869
2021
Q4
$8K Buy
38
+1
+3% +$211 ﹤0.01% 862
2021
Q3
$10K Buy
+37
New +$10K ﹤0.01% 844